Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 362 Show results per page	View Search Criteria \| Help With Results


1.		PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Completed				15 and over				Other				LAL-RI/96 NCT00494897


2.		Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)(COMPLETED)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care				Completed				18 and over				Pharmaceutical / Industry				P04594 NCT00687011


3.		Phase II Chemotherapy with MTX/CF, Aminopterin or M-BACOD plus CTX or BCG Immunotherapy for Advanced non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				25 to 65								DFCI-75116

Last Modified: 12/1/1989


4.		Phase II/III L-PAM/PRED/VCR vs VP-16/PRED/ADR for Stage II/III Myeloma (Summary Last Modified 12/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				20 and over								SAFR-CT-MM-2

Last Modified: 11/1/1988


5.		Phase II/III Pilot Study of Chemotherapy Consisting of Induction with VCR/ADR/ARA-C/6-MP/PRED Followed by Consolidation with CTX/ARA-C/6-MP and Maintenance with 6-MP/ARA-C/ADR in Children with AML (Summary Last Modified 11/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				under 20								ARG-GATLA-3LMA83

Last Modified: 5/1/2000


6.		Phase II/III Pilot Study of Combination Chemotherapy for Children with ALL in Relapse after Treatment on BFM Protocols (Summary Last Modified 05/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				under 20								ARG-GATLA-1LLAREC90 NCI-F92-0006, NCT00002499


7.		Treatment of Acute Lymphoblastic Leukemia or Aggressive Lymphoma With Relapse in Central Nervous System With Depocyt

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				18 and over				Other				GMALL06 NCT00199108

Last Modified: 12/29/2008 First Published: 1/1/1994


8.		NCI HIGH PRIORITY CLINICAL TRIAL --- Phase III Randomized Study of Melphalan/Total Body Irradiation with Peripheral Blood Stem Cell Rescue vs VBMCP (Vincristine/Carmustine/Melphalan/Cyclophosphamide/Prednisone) Following Standard Induction for Previously Untreated Symptomatic Multiple Myeloma, with Further Randomization for Major Responders to Interferon alfa vs Observation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				70 and under				NCI				SWOG-9321 CLB-9312, E-S9321, INT-0141, NCT00002548

Last Modified: 5/24/2006


9.		Phase III Randomized Study of Bone Marrow Transplantation vs Prolonged Intensive Chemotherapy Following Remission Re-Induction after Early First Marrow Relapse in Children with Acute Lymphocytic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				at least 1 + under 20 at diag.				NCI				CCG-1941

Last Modified: 8/1/1995


10.		Phase III Randomized Study of DepoFoam-Encapsulated Cytarabine (DTC 101) vs Standard Intrathecal Therapy for Neoplastic Meningitis (Summary Last Modified 08/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				any age				Pharmaceutical / Industry				MSKCC-94129 NCI-V95-0661

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute